PMC:7594251 / 1668-1811 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":94,"end":102},"obj":"Disease"},{"id":"T8","span":{"begin":105,"end":113},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d limitations of the primary NMR methods in drug development.\n\n1. Introduction\nThe unexpected SARS-CoV-2/COVID-19 outbreak, with over 34 millio"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11156","span":{"begin":134,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"d limitations of the primary NMR methods in drug development.\n\n1. Introduction\nThe unexpected SARS-CoV-2/COVID-19 outbreak, with over 34 millio"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":44,"end":48},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"d limitations of the primary NMR methods in drug development.\n\n1. Introduction\nThe unexpected SARS-CoV-2/COVID-19 outbreak, with over 34 millio"}

{"project":"LitCovid-PubTator","denotations":[{"id":"20","span":{"begin":94,"end":104},"obj":"Species"},{"id":"21","span":{"begin":105,"end":113},"obj":"Disease"}],"attributes":[{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:2697049"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d limitations of the primary NMR methods in drug development.\n\n1. Introduction\nThe unexpected SARS-CoV-2/COVID-19 outbreak, with over 34 millio"}

{"project":"LitCovid-sentences","denotations":[{"id":"T16","span":{"begin":63,"end":65},"obj":"Sentence"},{"id":"T17","span":{"begin":66,"end":78},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d limitations of the primary NMR methods in drug development.\n\n1. Introduction\nThe unexpected SARS-CoV-2/COVID-19 outbreak, with over 34 millio"}